146 related articles for article (PubMed ID: 4123544)
1. Evolutionary significance of persistence of latent oncogenic virus information in vertebrates.
Hirschhorn K; Gabelman N; Price PM; Waxman S
Lancet; 1973 May; 1(7813):1158-9. PubMed ID: 4123544
[No Abstract] [Full Text] [Related]
2. Cell-mediated immunity to leukemia associated antigens in experimental models and in man.
Herberman RB
Hamatol Bluttransfus; 1976; 19():195-206. PubMed ID: 188727
[No Abstract] [Full Text] [Related]
3. The problem of viral carcinogenesis: present aspects and perspectives.
Magrassi F; Georgiades J
Boll Ist Sieroter Milan; 1971; 50(3):152-75. PubMed ID: 4336423
[No Abstract] [Full Text] [Related]
4. Antigens of virus-induced tumors.
Habel K
Adv Immunol; 1969; 10():229-50. PubMed ID: 4311886
[No Abstract] [Full Text] [Related]
5. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
Law LW
Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
[No Abstract] [Full Text] [Related]
6. Virus tumorigenesis and immunity: influence of immunostimulation and immunodepression.
Friedman H; Ceglowski WS
Johns Hopkins Med J Suppl; 1974; 3():187-209. PubMed ID: 4609083
[No Abstract] [Full Text] [Related]
7. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
Sjögren HO
Ann Med Exp Biol Fenn; 1966; 44(2):227-31. PubMed ID: 4290659
[No Abstract] [Full Text] [Related]
8. Viral aetiopathogenesis of tumors.
Klein E
Boll Ist Sieroter Milan; 1971; 50(3):140-51. PubMed ID: 4111986
[No Abstract] [Full Text] [Related]
9. Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
Hirsch MS
Johns Hopkins Med J Suppl; 1974; 3():177-85. PubMed ID: 4153909
[No Abstract] [Full Text] [Related]
10. Immunogenetics of cell surface antigens of mouse leukemia.
Old LJ; Stockert E
Annu Rev Genet; 1977; 11():127-60. PubMed ID: 202188
[No Abstract] [Full Text] [Related]
11. Immunodepression by viruses.
Salaman MH
Antibiot Chemother; 1969; 15():393-406. PubMed ID: 4305394
[No Abstract] [Full Text] [Related]
12. A critical review of immunologic investigation and immune therapy in leukemias.
Berceanu S; Gociu M
Rev Roum Med Intern; 1973; 10(2):75-90. PubMed ID: 4126159
[No Abstract] [Full Text] [Related]
13. The immune response to virally determined tumor associated antigens.
Lamon EW
Biochim Biophys Acta; 1974 Sep; 355(2):149-76. PubMed ID: 4370470
[No Abstract] [Full Text] [Related]
14. [New antigens induced by oncogenic viruses].
Kosiakova NP
Usp Sovrem Biol; 1982; 93(3):433-47. PubMed ID: 7051606
[No Abstract] [Full Text] [Related]
15. The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes.
Del Vellano BC; Nave B; Croker BP; Lerner RA; Dixon FJ
J Exp Med; 1975 Jan; 141(1):172-87. PubMed ID: 46909
[TBL] [Abstract][Full Text] [Related]
16. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
Herberman RB
J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
[No Abstract] [Full Text] [Related]
17. Antigenic comparison of bovine type C virus with murine and feline leukemia viruses.
Ferrer JF
Cancer Res; 1972 Sep; 32(9):1871-7. PubMed ID: 4345040
[No Abstract] [Full Text] [Related]
18. Development of tumors as a result of graft-versus-host reaction.
Cornelius EA
Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
[No Abstract] [Full Text] [Related]
19. Feline virus-induced tumors and the immune response: recent developments.
Essex M; Cotter SM; Carpenter JL
Am J Vet Res; 1973 Jun; 34(6):809-12. PubMed ID: 4350543
[No Abstract] [Full Text] [Related]
20. Immunogenetic approach to neoplasia.
Tennant JR
Transplant Proc; 1970 Mar; 2(1):104-16. PubMed ID: 4107289
[No Abstract] [Full Text] [Related]
[Next] [New Search]
